Log in
LON:PRTC

PureTech Health Share Forecast, Price & News

GBX 261
+4.00 (+1.56 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
248.25
Now: GBX 261
265
50-Day Range
256
MA: GBX 273.52
289.50
52-Week Range
191.20
Now: GBX 261
339.36
Volume107,489 shs
Average Volume187,275 shs
Market Capitalization£745.54 million
P/E Ratio1.65
Dividend YieldN/A
BetaN/A
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.
Read More
PureTech Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.84 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-617-4822333

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£12.26 million
Cash FlowGBX 121.76 per share
Book ValueGBX 274.50 per share

Profitability

Miscellaneous

Employees300
Market Cap£745.54 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 261
+4.00 (+1.56 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PureTech Health (LON:PRTC) Frequently Asked Questions

How has PureTech Health's stock been impacted by COVID-19 (Coronavirus)?

PureTech Health's stock was trading at GBX 274 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PRTC stock has decreased by 4.7% and is now trading at GBX 261.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of PureTech Health?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PureTech Health in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for PureTech Health
.

What price target have analysts set for PRTC?

3 Wall Street analysts have issued 12 month price targets for PureTech Health's stock. Their forecasts range from GBX 480 to GBX 490. On average, they expect PureTech Health's stock price to reach GBX 483.33 in the next twelve months. This suggests a possible upside of 85.2% from the stock's current price.
View analysts' price targets for PureTech Health
.

Who are some of PureTech Health's key competitors?

What other stocks do shareholders of PureTech Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PureTech Health investors own include Nemaska Lithium (NMX), Yamana Gold (YRI), Asanko Gold (AKG), Arotech (ARTX), Boeing (BA), Baozun (BZUN), Chaarat Gold (CGH), Eldorado Gold (ELD), CarMax (KMX) and Knowles (KN).

Who are PureTech Health's key executives?

PureTech Health's management team includes the following people:
  • Ms. Daphne Zohar, Founder, CEO & Exec. Director (Age 47)
  • Dr. Bennett M. Shapiro, Co-Founder & Non-Exec. Director (Age 78)
  • Dr. Robert S. Langer Jr., Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board (Age 69)
  • Mr. Stephen M. Muniz J.D., COO, Exec. VP of Legal & Operations, Sec. and Exec. Director (Age 48)
  • Dr. Bharatt M. Chowrira, Pres and Chief of Bus. & Strategy (Age 53)

What is PureTech Health's stock symbol?

PureTech Health trades on the London Stock Exchange (LON) under the ticker symbol "PRTC."

How do I buy shares of PureTech Health?

Shares of PRTC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is PureTech Health's stock price today?

One share of PRTC stock can currently be purchased for approximately GBX 261.

How big of a company is PureTech Health?

PureTech Health has a market capitalization of £745.54 million and generates £12.26 million in revenue each year. PureTech Health employs 300 workers across the globe.

What is PureTech Health's official website?

The official website for PureTech Health is puretechhealth.com.

How can I contact PureTech Health?

PureTech Health's mailing address is 501 Boylston St Ste 6102, BOSTON, MA 02116-3769, United States. The company can be reached via phone at +1-617-4822333.

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.